|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)
Chemistry
| Test | 21 Jun 2017 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 276.2 H | 130 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 125.2 | 35 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 192.9 H | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58.3 | 46 - 82 | mg/dL |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows elevated total cholesterol and LDL cholesterol levels, while triglycerides and HDL cholesterol are within normal limits. These findings indicate increased cardiovascular risk and suggest the need for lifestyle modification and possible further evaluation for dyslipidemia. Clinical correlation and follow-up are recommended. |